Comments

Icon

Q: What sector and industry does Icon (ICLR) operate in?

Icon is in the Healthcare sector and Diagnostics & Research industry. They are listed on the NASDAQ.

ICLRNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$201.39

-0.45-0.22%

At close: -

$201.39

0.000.00%

After Hours: 4:37 PM EDT

Q4 2024 Earnings were released on Wed Feb 19th, after the market close

The most recent conference call was at 8:00 AM, 1 day ago Click to view past webcast

Icon (ICLR) Forecast

News Earnings Icon (ICLR) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Edge Rankings

Want to View Edge Rankings?

Unlock The Hidden Results With Your Benzinga Account Now.

Get Started

Icon (NASDAQ:ICLR) Stock Quotes, Forecast and News Summary

Icon Stock (NASDAQ: ICLR) stock price, news, charts, stock research, profile.

Open	$204.68
Close	$201.39
Volume / Avg.	1.35M / 1.03M
Day Range	$200.77 - $208.95
52 Wk Range	181.51 - 347.72
Market Cap	$16.63B
P/E Ratio	21.18
Dividend Yield	-
Exchange	NASDAQ
RSI	55
Short Interest	1.7%
Days to Cover	1.51

Recent News

Elliott Investment Management Bets Against Nvidia In Q4 (CORRECTED)

Elliott Investment Management made several portfolio moves in the fourth quarter, closing multiple options positions and shaking up the activist firm's technology exposure.

Adam Eckert

Moderna, GameStop And Snap Are Among Top Large-Cap Losers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?

Eleven large-cap stocks were the worst performers in the last week. Short positions announced for FTAI, revenue updates for MRNA, and price forecasts changed for GME, SNAP, RKLB, NTRA, LLY, ICLR, BNTX, NVO, and BMRN.

Lekha Gupta

Clinical Research Firm ICON Faces Headwinds From Top Customers And Biotech Recovery Uncertainty

ICON forecasts 2025 revenue at $8.05 billion–$8.65 billion and adjusted EPS of $13.00–$15.00, citing biopharma spending cuts and biotech recovery delays.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Jan

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$204.68
Close	$201.39
Volume / Avg.	1.35M / 1.03M
Day Range	$200.77 - $208.95
52 Wk Range	181.51 - 347.72
Market Cap	$16.63B
P/E Ratio	21.18
Dividend Yield	-
Exchange	NASDAQ
RSI	55
Short Interest	1.7%
Days to Cover	1.51

About

Sector

Healthcare

Industry

N/A

Icon is a global late-stage contract research organization that provides drug development and clinic...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Icon (ICLR) stock?

You can purchase shares of Icon (NASDAQ:ICLR) through any online brokerage.

View our list of the best stock brokerages

Who are Icon (ICLR) competitors?

There are no as such competitors for Icon.

What is the forecast, or price target, for Icon (ICLR) stock?

Icon has a consensus price target of $272.63.

What is the current price for Icon (ICLR)?

The stock price for Icon (NASDAQ: ICLR) is $201.39 last updated February 21, 2025 at 4:37 PM EST.

Does Icon (ICLR) pay a dividend?

There are no upcoming dividends for Icon.

When is Icon (NASDAQ:ICLR) reporting earnings?

Icon’s Q1 earnings are confirmed for Wednesday, April 23, 2025.

Is Icon (ICLR) going to split?

There is no upcoming split for Icon.

What sector and industry does Icon (ICLR) operate in?

Icon is in the Healthcare sector and Diagnostics & Research industry. They are listed on the NASDAQ.